Thermo Fisher Scientific Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS, a Precursor to Multiple Myeloma
BIRMINGHAM, England--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite® Freelite®...
Zur Pressemeldung auf newsroom.thermofisher.com